Jeffrey Small, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Teleflex LLC accounts for 68.8% of it on its own, with 5 other manufacturers making up the rest. Among surgical clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $57.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$1K
- Procept Biorobotics Corporation$208
- Boston Scientific$201
- C. R. Bard, Inc. & Subsidiaries$54
- Calyxo, Inc.$47
- Tolmar, Inc.$24
What the payments were for
- Food & beverage$1,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 21 | $1,181 |
| Procept Biorobotics Corporation | 2 | $208 |
| Boston Scientific | 2 | $201 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $54 |
| Calyxo, Inc. | 2 | $47 |
| Tolmar, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$495
- AQUABEAM SYSTEM$195
- UroLift System$141
- Barrigel$123
- GENERAL ERECTILE DYSFUNCTION$103
How this compares
$1,716 in reported general payments places this provider in the 90th percentile of 312 surgical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 340 | $208,978 |
| GemtesaVibegron | 96 | $83,066 |
| Tamsulosin Hcl | 1,408 | $26,092 |
| Mirabegron ErMirabegron | 26 | $16,317 |
| Solifenacin Succinate | 111 | $7,892 |
| Finasteride | 514 | $7,855 |
| Methenamine Hippurate | 77 | $6,093 |
| Trospium Chloride ErTrospium Chloride | 42 | $5,606 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 178 | $4,696 |
| Oxybutynin Chloride ErOxybutynin Chloride | 175 | $4,545 |
| Trospium Chloride | 68 | $3,926 |
| Estradiol | 49 | $3,816 |
| Tolterodine Tartrate ErTolterodine Tartrate | 17 | $2,639 |
| Potassium Citrate ErPotassium Citrate | 17 | $2,419 |
| Oxybutynin Chloride | 89 | $2,267 |
Paid to pharmacies, not to this prescriber.
Other surgical in Salem
- Adele ComiteSalem$1K
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
- Nicolas DesjardinsSomerville$10K
- Robert KenneyChestnut Hill$8K
- Michael LlewellynBoston$8K
- Anargyros SkaliotisNorth Dartmouth$7K
- Caily IrwinCambridge$6K
- Courtney FioreDanvers$6K
- Dana GoldenseBoston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.